Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michael Chrobook"'
Autor:
G. Gahrton, Nicole Marquardt, Charlotte Gran, Arnika Kathleen Wagner, Gabriel Afram, Hareth Nahi, Birgitta Stellan, Johan Liwing, Monika Klimkowska, Hans-Gustaf Ljunggren, Evren Alici, Tolga Sutlu, Michael Chrobook, Mari Gilljam, Lilian Walther-Jallow, Stephan Meinke, Per Ljungman
Publikováno v:
Blood. 138:4796-4796
Introduction: Immunotherapies are gaining more and more importance in the treatment of multiple myeloma (MM). Antibodies directed against MM antigens like CD38, SLAMF7 or BCMA are used either in their natural form, conjugated to drugs, or in the form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a05def2800b19cd9bb5453e089af9267
https://doi.org/10.1182/blood-2021-152522
https://doi.org/10.1182/blood-2021-152522
Autor:
Karl-Johan Malmberg, Jeffrey S. Miller, Sarah Cooley, Eivind Heggernes Ask, Ebba Sohlberg, Eva Hellström-Lindberg, Merete Thune Wiiger, Andreas T. Björklund, Michael Chrobook, Bahram Valamehr, Evren Alici, Alvaro Haroun-Izquierdo, Karolin Guldevall, Hanna van Ooijen, Veronika Kremer, Hans-Gustaf Ljunggren, Hanna Julie Hoel, Björn Önfelt, Jodie P. Goodridge, Blomberg Pontus, Aline Pfefferle
Publikováno v:
Blood. 132:195-195
Natural killer (NK) cells hold great promise as a source for allogeneic cell therapy against hematological malignancies, including acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). NK cell recognition of allogeneic tumors is strictly r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8f41c8662e500fef05067501830f712
https://doi.org/10.1182/blood-2018-195
https://doi.org/10.1182/blood-2018-195